Pipeline
A Brighter Future In Cancer
At GenLumina, we’re focused on developing light-activated cancer treatments. By combining our nanocluster technology with antibodies, biomarkers, peptides and advanced imaging techniques we aim to precisely target and treat cancer cells.
Current focus Areas
Skin Cancer Treatment
Starting with basal cell carcinoma, we are proving the efficacy of our light-activated technology in real-world applications.
Expanding to Other Cancer Types
We are utilizing our platform’s adaptability to expand to a wide range of cancers, aiming to make a greater impact on patients’ lives.
“A better, more tumor-selective and less toxic treatment for skin cancers is eagerly awaited. The light-activated DNA-silver constructs provide a new opportunity to explore highly selective treatment of superficial cancers.”
Wouter Vogel
NKI, Nuclear Oncologist
Collaborate With Us
Partners
We’re seeking partners for proof-of-concept research in various cancers. Our customizable DNA technology integrates with imaging techniques for precise cancer localization and targeted treatments, making it ideal for use with antibodies, peptides, and other markers.
Specialists
As we approach clinical trials, we’re seeking partners to help bring our treatments to patients. We’re looking for leaders in oncology and pharmaceutical development to collaborate on early-stage clinical trials.
Integration
We are committed to making these treatments accessible to patients worldwide. Our platform can integrate with existing cancer treatments, such as radiotherapy, immunotherapy, and surgery to improve overall patient outcomes.
Learn more
“A more effective photodynamic treatment would make tens of thousands of surgical procedures with complications, disturbing scars, and multiple hospital visits unnecessary every year.”
Remco van Doorn
LUMC, Dermatologist
Our technology doesn’t just treat cancer;
it’s designed to reshape we manage cancer globally.